These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10821456)

  • 1. Quality use of allopurinol in the elderly.
    Smith P; Karlson N; Nair BR
    J Qual Clin Pract; 2000 Mar; 20(1):42-3. PubMed ID: 10821456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding and improving the use of allopurinol in a teaching hospital.
    Hmar RC; Kannangara DR; Ramasamy SN; Baysari MT; Williams KM; Day RO
    Intern Med J; 2015 Apr; 45(4):383-90. PubMed ID: 25644128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate prescription of allopurinol in a teaching hospital.
    Athisakul S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 May; 90(5):889-94. PubMed ID: 17596042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunities for improving medication use and monitoring in gout.
    Singh JA; Hodges JS; Asch SM
    Ann Rheum Dis; 2009 Aug; 68(8):1265-70. PubMed ID: 18701554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapy.
    Keith MP; Gilliland WR
    Clin Pharmacol Ther; 2011 Sep; 90(3):363-4. PubMed ID: 21862966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD).
    Mikuls TR; Farrar JT; Bilker WB; Fernandes S; Saag KG
    Rheumatology (Oxford); 2005 Aug; 44(8):1038-42. PubMed ID: 15870145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of allopurinol in the Australian community.
    Chung Y; Lu CY; Graham GG; Mant A; Day RO
    Intern Med J; 2008 Jun; 38(6):388-95. PubMed ID: 18422564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Influencing Allopurinol Initiation in Primary Care.
    Clarson LE; Hider SL; Belcher J; Roddy E; Mallen CD
    Ann Fam Med; 2017 Nov; 15(6):557-560. PubMed ID: 29133496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Febuxostat efficacy in allopurinol-resistant tophaceous gout.
    Uh M; Reid G
    J Clin Rheumatol; 2011 Jun; 17(4):204-6. PubMed ID: 21617552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of adherence and persistence with allopurinol therapy among gout patients in Israel.
    Zandman-Goddard G; Amital H; Shamrayevsky N; Raz R; Shalev V; Chodick G
    Rheumatology (Oxford); 2013 Jun; 52(6):1126-31. PubMed ID: 23392592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febuxostat versus allopurinol for gout.
    Lustberg ME
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16598054
    [No Abstract]   [Full Text] [Related]  

  • 15. Up-titration of allopurinol in patients with gout.
    Jennings CG; Mackenzie IS; Flynn R; Ford I; Nuki G; De Caterina R; Riches PL; Ralston SH; MacDonald TM;
    Semin Arthritis Rheum; 2014 Aug; 44(1):25-30. PubMed ID: 24560169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of gout: not always simple].
    van Vugt RM; Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 1996 Jan; 140(4):177-9. PubMed ID: 8618639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Allopurinol efficacy in patients with tophus gout and chronic renal failure].
    Iakunina IA; Barskova VG; Nasonova VA
    Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370
    [No Abstract]   [Full Text] [Related]  

  • 19. Effective management of gout.
    Weinstein J
    Am J Med; 1999 Oct; 107(4):406. PubMed ID: 10527052
    [No Abstract]   [Full Text] [Related]  

  • 20. Allopurinol versus rilonacept for the prevention of gout flares: comment on the article by Schumacher et al.
    Meltzer M
    Arthritis Care Res (Hoboken); 2013 May; 65(5):838. PubMed ID: 23281274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.